Maria Lund

Maria Lund is an accomplished professional in the field of life sciences with extensive experience in investment and preclinical development. Currently serving as Investment Manager and previously as Investment Analyst at IP Group plc since September 2021, Maria brings valuable insights from roles such as Senior Scientist and Preclinical Program Lead at GlyTherix Ltd from 2018 to 2021 and Postdoctoral Scientist at Minomic International Ltd from 2016 to 2017. Academic credentials include a Doctor of Philosophy (PhD) in Immunology and a Bachelor of Medical Science (Honors) from the University of Technology Sydney. Additional training includes completion of the Company Directors Course at the Australian Institute of Company Directors in 2022.